药物对比
Propoxyphene vs Nalbuphine
比较 Propoxyphene 与 Nalbuphine：已撤市的阿片类药物 vs 混合激动剂‑拮抗剂。心脏风险 vs 黑框警告。哪个更适合疼痛管理？
此页面暂无可用的对比维度。
临床背景
This comparison is triggered when evaluating remaining options for moderate-to-severe pain after Propoxyphene's market withdrawal or considering mixed agonist-antagonists versus older oral opioids.
结论
Nalbuphine is the more viable remaining option since Propoxyphene was withdrawn for cardiac toxicity.
全部药物对比